Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
journalStr:"Cancer chemotherapy and pharmacology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22&lookfor=%22Curtin%2C+Nicola%22&type=Person
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22&lookfor=%22Curtin%2C+Nicola%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22Cancer+chemotherapy+and+pharmacology%22&lookfor=%22Curtin%2C+Nicola%22&type=Person
PubPharm (9)
1
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
enthalten in:
Cancer chemotherapy and pharmacology
| 2013
von
Plummer, R.
|
Lorigan, P.
|
Steven, N.
| +10
Wird geladen...
2
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
enthalten in:
Cancer chemotherapy and pharmacology
| 2013
von
Plummer, R.
|
Lorigan, P.
|
Steven, N.
| +10
Wird geladen...
3
A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation
enthalten in:
Cancer chemotherapy and pharmacology
| 2013
von
Plummer, R.
|
Lorigan, P.
|
Steven, N.
| +10
Wird geladen...
4
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
enthalten in:
Cancer chemotherapy and pharmacology
| 2012
von
Tavecchio, M.
|
Munck, J.
|
Cano, C.
| +2
Wird geladen...
5
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
enthalten in:
Cancer chemotherapy and pharmacology
| 2011
von
Tavecchio, M.
|
Munck, J.
|
Cano, C.
| +2
Wird geladen...
6
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
enthalten in:
Cancer chemotherapy and pharmacology
| 2011
von
Tavecchio, M.
|
Munck, J.
|
Cano, C.
| +2
Wird geladen...
7
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
enthalten in:
Cancer chemotherapy and pharmacology
| 2010
von
Zaremba, T.
|
Thomas, H.
|
Cole, M.
| +2
Wird geladen...
8
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
enthalten in:
Cancer chemotherapy and pharmacology
| 2010
von
Zaremba, T.
|
Thomas, H.
|
Cole, M.
| +2
Wird geladen...
9
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
enthalten in:
Cancer chemotherapy and pharmacology
| 2010
von
Zaremba, T.
|
Thomas, H.
|
Cole, M.
| +2
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Zeitschrift: Cancer chemotherapy and pharmacology
Medienart
9
Aufsätze
9
E-Artikel
E-Ressourcen
Zeitschriftentitel
Cancer chemotherapy and pharmacology
Thema
4
Doxorubicin
3
Journal Article
3
Research Support, Non-U.S. Gov't
2
80168379AG
2
Chemo- and radio-potentiation
2
Chemopotentiation
2
DNA repair
2
DNA-PK
2
HR
2
Melanoma
2
Monozygotic twins
2
NU7441
2
PARP
2
PARP inhibitors
2
PARP-1
2
PARP-1 activity
2
PARP-1 expression
2
Phase II
2
Poly(ADP-ribose) Polymerase Inhibitors
2
Rad51
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2013
1
2012
2
2011
3
2010
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...